Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2024-12-25T05:27:34.577Z Has data issue: false hasContentIssue false
  • English
  • Français

Spontaneous hyperactivity in mutant mice lacking the NMDA receptor GluRε1 subunit is aggravated during exposure to 0.1 MAC sevoflurane and is preserved after emergence from sevoflurane anaesthesia

Published online by Cambridge University Press:  01 December 2008

A. B. Petrenko ,
T. Kohno ,
J. Wu ,
K. Sakimura  and
H. Baba
A. B. Petrenko*
Affiliation:
Niigata University Graduate School of Medical and Dental Sciences, Division of Anesthesiology, Niigata, Japan
T. Kohno
Affiliation:
Niigata University Graduate School of Medical and Dental Sciences, Division of Anesthesiology, Niigata, Japan
J. Wu
Affiliation:
Niigata University Graduate School of Medical and Dental Sciences, Division of Anesthesiology, Niigata, Japan
K. Sakimura
Affiliation:
Niigata University, Brain Research Institute, Department of Cellular Neurobiology, Niigata, Japan
H. Baba
Affiliation:
Niigata University Graduate School of Medical and Dental Sciences, Division of Anesthesiology, Niigata, Japan
*
Correspondence to: Andrey B. Petrenko, Division of Anesthesiology, Niigata University Graduate School of Medical and Dental Sciences, Asahimachi 1-757, Niigata 951-8510, Japan. E-mail: [email protected]; Tel: +81 25 227 2328; Fax: +81 25 227 0790
Get access

Summary

Background and objective

Patients who awake from sevoflurane anaesthesia with symptoms of agitation may have some underlying functional substrate that is sensitive to the low concentrations of anaesthetic encountered during emergence. One candidate for such a substrate could be neurocircuitry implied in the pathophysiology of both agitation and movement disorders with hyperactivity. We postulated that hyperactive animals would show a further increase in activity in the presence of low concentrations of volatile anaesthetics, such as sevoflurane.

Methods

To confirm our hypothesis, we examined the effects of two subanaesthetic concentrations of sevoflurane, isoflurane and halothane (0.1 and 0.2 MAC (minimum alveolar concentration)) on spontaneous activity in N-methyl-d-aspartate receptor GluRε1 subunit knockout mice exhibiting locomotor hyperactivity in a novel environment and compared these results with those for wild-type controls. We also compared the effects of anaesthetic concentrations of sevoflurane (1.2 MAC) on mice activity during postanaesthesia recovery.

Results

Out of the three anaesthetics used, only sevoflurane administered at 0.1 MAC caused a significantly different response between the two experimental groups. Exposure to this subanaesthetic concentration of sevoflurane reduced the activity of wild-type mice, whereas mutant animals showed a further increase in hyperactivity. The effects of 1.2 MAC sevoflurane anaesthesia on mice activity during postanaesthesia recovery also differed significantly between the two genotypes. Exposure to anaesthetic concentrations of sevoflurane had a sedative effect on wild-type mice, whereas mutant mice preserved their high levels of activity upon emergence from the anaesthesia.

Conclusions

The presence of an inherent anomaly in mutant mice that becomes more manifest during exposure to 0.1 MAC sevoflurane and is still present after the emergence from sevoflurane anaesthesia suggests the presence of and necessitates a search for some putative substrate that may, by analogy, underlie emergence agitation in the clinical setting.

Keywords

ANAESTHETICS INHALATION, sevofluraneNMDA RECEPTORSGluRε1KNOCKOUT MICELOCOMOTOR ACTIVITY, drug effects
Type
Original Article
Information
European Journal of Anaesthesiology , Volume 25 , Issue 12 , December 2008 , pp. 953 - 960
Copyright
Copyright © European Society of Anaesthesiology 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Vlajkovic, GP, Sindjelic, RP. Emergence delirium in children: many questions, few answers. Anesth Analg 2007; 104: 84–91.CrossRefGoogle ScholarPubMed
2.Kain, ZN, Caldwell-Andrews, AA, Maranets, I et al. Preoperative anxiety and emergence delirium and postoperative maladaptive behaviors. Anesth Analg 2004; 99: 1648–1654.CrossRefGoogle ScholarPubMed
3.Wright, KD, Stewart, SH, Finley, GA, Buffett-Jerrott, SE. Prevention and intervention strategies to alleviate preoperative anxiety in children: a critical review. Behav Modif 2007; 31: 52–79.CrossRefGoogle ScholarPubMed
4.Kain, ZN, Mayes, LC, Caldwell-Andrews, AA, Karas, DE, McClain, BC. Preoperative anxiety, postoperative pain, and behavioral recovery in young children undergoing surgery. Pediatrics 2006; 118: 651–658.CrossRefGoogle ScholarPubMed
5.Kain, ZN, Caldwell-Andrews, AA, Mayes, LC et al. Family-centered preparation for surgery improves perioperative outcomes in children: a randomized controlled trial. Anesthesiology 2007; 106: 65–74.CrossRefGoogle ScholarPubMed
6.Lindenmayer, JP. The pathophysiology of agitation. J Clin Psychiatry 2000; 61 (Suppl 14): 5–10.Google ScholarPubMed
7.Ogasawara, H. Effects of sevoflurane anesthesia on norepinephrine metabolism in rat brain. Masui 1992; 41: 78–85.Google ScholarPubMed
8.Ogasawara, H, Kudo, T, Kudo, M, Ishihara, H, Matsuki, A. Effects of sevoflurane anesthesia on dopamine metabolism in the rat brain. Masui 1992; 41: 1723–1729.Google ScholarPubMed
9.Ogasawara, H, Takahashi, S, Kudo, T et al. Effects of sevoflurane anesthesia on serotonin metabolism in rat brain. Masui 1993; 42: 1412–1417.Google ScholarPubMed
10.Sakimura, K, Kutsuwada, T, Ito, I et al. Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor ε1 subunit. Nature 1995; 373: 151–155.CrossRefGoogle Scholar
11.Miyamoto, Y, Yamada, K, Noda, Y et al. Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor ε1 subunit. J Neurosci 2001; 21: 750–757.CrossRefGoogle ScholarPubMed
12.Mori, H, Mishina, M. Roles of diverse glutamate receptors in brain functions elucidated by subunit-specific and region-specific gene targeting. Life Sci 2003; 74: 329–336.CrossRefGoogle ScholarPubMed
13.Honma, S, Honma, K. Light-induced uncoupling of multioscillatory circadian system in a diurnal rodent, Asian chipmunk. Am J Physiol 1999; 276: R1390–R1396.Google Scholar
14.Sato, Y, Kobayashi, E, Murayama, T, Mishina, M, Seo, N. Effect of N-methyl-D-aspartate receptor ε1 subunit gene disruption of the action of general anesthetic drugs in mice. Anesthesiology 2005; 102: 557–561.CrossRefGoogle ScholarPubMed
15.Petrenko, AB, Tsujita, M, Kohno, T, Sakimura, K, Baba, H. Mutation of alpha1G T-type calcium channels in mice does not change anesthetic requirements for loss of the righting reflex and minimum alveolar concentration but delays the onset of anesthetic induction. Anesthesiology 2007; 106: 1177–1185.CrossRefGoogle Scholar
16.Fishman, RH, Feigenbaum, JJ, Yanai, J, Klawans, HL. The relative importance of dopamine and norepinephrine in mediating locomotor activity. Prog Neurobiol 1983; 20: 55–88.CrossRefGoogle ScholarPubMed
17.Chevalier, G, Deniau, JM. Disinhibition as a basic process in the expression of striatal functions. Trends Neurosci 1990; 13: 277–280.CrossRefGoogle ScholarPubMed
18.Sachdev, P, Kruk, J. Restlessness: the anatomy of a neuropsychiatric symptom. Aust N Z J Psychiatry 1996; 30: 38–53.CrossRefGoogle ScholarPubMed
19.Liljequist, S, Ossowska, K, Grabowska-Anden, M, Anden, NE. Effect of the NMDA receptor antagonist, MK-801, on locomotor activity and on the metabolism of dopamine in various brain areas of mice. Eur J Pharmacol 1991; 195: 55–61.CrossRefGoogle Scholar
20.Burns, LH, Everitt, BJ, Kelley, AE, Robbins, TW. Glutamate-dopamine interactions in the ventral striatum: role in locomotor activity and responding with conditioned reinforcement. Psychopharmacology (Berl) 1994; 115: 516–528.CrossRefGoogle ScholarPubMed
21.Irifune, M, Shimizu, T, Nomoto, M, Fukuda, T. Involvement of N-methyl-D-aspartate (NMDA) receptors in noncompetitive NMDA receptor antagonist-induced hyperlocomotion in mice. Pharmacol Biochem Behav 1995; 51: 291–296.CrossRefGoogle ScholarPubMed
22.Adriani, W, Felici, A, Sargolini, F et al. N-methyl-D-aspartate and dopamine receptor involvement in the modulation of locomotor activity and memory processes. Exp Brain Res 1998; 123: 52–59.CrossRefGoogle ScholarPubMed
23.Tiedtke, PI, Bischoff, C, Schmidt, WJ. MK-801-induced stereotypy and its antagonism by neuroleptic drugs. J Neural Transm Gen Sect 1990; 81: 173–182.CrossRefGoogle ScholarPubMed
24.Yamamoto, M, Mizuki, Y, Suetsugi, M et al. Effects of dopamine antagonists on changes in spontaneous EEG and locomotor activity in ketamine-treated rats. Pharmacol Biochem Behav 1997; 57: 361–365.CrossRefGoogle ScholarPubMed
25.Adachi, Y, Taoda, M, Uchihashi, Y, Watanabe, K, Satoh, T. The effect of sevoflurane and isoflurane on striatal dopamine of awake freely moving rats observed in an in vivo microdialysis study. Masui 1999; 48: 960–965.Google Scholar
26.Adachi, Y, Uchihashi, Y, Watanabe, K, Satoh, T. Halothane anesthesia decreases the extracellular level of dopamine in rat striatum: a microdialysis study in vivo. J Anesth 2000; 14: 82–90.CrossRefGoogle ScholarPubMed
27.Zhang, Y, Eger, EI 2nd, Dutton, RC, Sonner, JM. Inhaled anesthetics have hyperalgesic effects at 0.1 minimum alveolar anesthetic concentration. Anesth Analg 2000; 91: 462–466.Google ScholarPubMed
28.Otsubo, T, Nakamura, Y, Nagai, T, Hori, Y. Facilitatory action of halothane at subanesthetic concentrations on glutamatergic excitatory synaptic transmission in the CA1 area of adult rat hippocampus. Neurosci Lett 2003; 337: 139–142.CrossRefGoogle ScholarPubMed
29.Adachi, Y, Higuchi, H, Watanabe, K et al. The effect of halothane or sevoflurane anesthesia on the extracellular concentration of dopamine and its metabolites examined by in vivo microdialysis techniques. Masui 2006; 55: 1452–1458.Google ScholarPubMed
30.Chang, CK, Wang, NL, Lin, MT. Inhibition of the dopamine system in rat amygdala attenuates the picrotoxin-induced locomoter hyperactivity and hypertension. Clin Exp Pharmacol Physiol 2004; 31: 284–288.CrossRefGoogle ScholarPubMed
31.Alkire, MT, Nathan, SV, McReynolds, JR. Memory enhancing effect of low-dose sevoflurane does not occur in basolateral amygdala-lesioned rats. Anesthesiology 2005; 103: 1167–1173.CrossRefGoogle Scholar
32.Hatzakorzian, R, Shan, WL, Cote, AV, Schricker, T, Backman, SB. The management of severe emergence agitation using droperidol. Anaesthesia 2006; 61: 1112–1115.CrossRefGoogle ScholarPubMed
33.Buttner, M, Walder, B, von Elm, E, Tramer, MR. Is low-dose haloperidol a useful antiemetic? A meta-analysis of published and unpublished randomized trials. Anesthesiology 2004; 101: 1454–1463.CrossRefGoogle ScholarPubMed
34.Mehler-Wex, C, Riederer, P, Gerlach, M. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson’s disease, schizophrenia and attention deficit hyperactivity disorder. Neurotox Res 2006; 10: 167–179.CrossRefGoogle ScholarPubMed
35.Nigg, JT, Casey, BJ. An integrative theory of attention-deficit/hyperactivity disorder based on the cognitive and affective neurosciences. Dev Psychopathol 2005; 17: 785–806.CrossRefGoogle ScholarPubMed
36.Ernst, M, Zametkin, AJ, Matochik, JA et al. High midbrain [18F]DOPA accumulation in children with attention deficit hyperactivity disorder. Am J Psychiatry 1999; 156: 1209–1215.CrossRefGoogle ScholarPubMed
37.Solanto, MV. Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research. Behav Brain Res 2002; 130: 65–71.CrossRefGoogle ScholarPubMed
38.Biederman, J, Faraone, SV. Attention-deficit hyperactivity disorder. Lancet 2005; 366: 237–248.CrossRefGoogle ScholarPubMed
39.Greydanus, DE, Pratt, HD, Patel, DR. Attention deficit hyperactivity disorder across the lifespan: the child, adolescent, and adult. Dis Mon 2007; 53: 70–131.CrossRefGoogle ScholarPubMed
40.Forsyth, I, Bergesio, R, Chambers, NA. Attention-deficit hyperactivity disorder and anesthesia. Paediatr Anaesth 2006; 16: 371–373.CrossRefGoogle ScholarPubMed